LAP3
| Official symbol: | LAP3 |
| Full name: | leucine aminopeptidase 3 |
| Location: | 4p15.32 |
| Also known as: | LAP, LAPEP, PEPS |
| Entrez ID: | 51056 |
| Ensembl ID: | ENSG00000002549 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 3 |
|
|
| Fusions detected in 3 cancer type(s) |
|
| |
|
|
|
| Functional class: | Enzyme |
| JensenLab PubMed score: | 385.71 (Percentile rank: 88.70%) |
| PubTator score: | 122.37 (Percentile rank: 80.33%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Clinical PrecedenceTargets with drugs in phase II or above; Pre-clinical targets |
| Tractability (antibody): | |
